Full text loading...
Management of autoimmune and immune-mediated skin diseases
/content/chapter/10.22233/9781910443811.chap29
Management of autoimmune and immune-mediated skin diseases
- Authors: Hilary A. Jackson and Katharine F. Lunn
- From: BSAVA Manual of Canine and Feline Dermatology
- Item: Chapter 29, pp 218 - 225
- DOI: 10.22233/9781910443811.29
- Copyright: © 2021 British Small Animal Veterinary Association
- Publication Date: September 2021
Abstract
This chapter covers the treatment goals, treatment strategies, specific therapeutics and pain relief for autoimmune and immune-mediated skin diseases.
Preview this chapter:
Management of autoimmune and immune-mediated skin diseases, Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/10.22233/9781910443811/BSAVA_Manual_Canine_Feline_Dermatology_4_9781910443811.29.218-225-1.gif
/content/chapter/10.22233/9781910443811.chap29
Figures
/content/figure/10.22233/9781910443811.chap29.fig29_3
29.3
Localized epidermal atrophy, calcinosis cutis and secondary infection caused by repeated application of a topical glucocorticoid. © 2021 British Small Animal Veterinary Association
10.22233/9781910443811/fig29_3_thumb.gif
10.22233/9781910443811/fig29_3.png
29.3
Localized epidermal atrophy, calcinosis cutis and secondary infection caused by repeated application of a topical glucocorticoid.
/content/figure/10.22233/9781910443811.chap29.fig29_4
29.4
Calcinosis cutis on the dorsal neck that developed after glucocorticoid therapy for pemphigus foliaceus. © 2021 British Small Animal Veterinary Association
10.22233/9781910443811/fig29_4_thumb.gif
10.22233/9781910443811/fig29_4.png
29.4
Calcinosis cutis on the dorsal neck that developed after glucocorticoid therapy for pemphigus foliaceus.
/content/figure/10.22233/9781910443811.chap29.fig29_5
29.5
Epidermal atrophy and skin tearing in a cat after systemic glucocorticoid therapy. © 2021 British Small Animal Veterinary Association
10.22233/9781910443811/fig29_5_thumb.gif
10.22233/9781910443811/fig29_5.png
29.5
Epidermal atrophy and skin tearing in a cat after systemic glucocorticoid therapy.
/content/figure/10.22233/9781910443811.chap29.fig29_6
29.6
Ear tip curling as a result of systemic glucocorticoid therapy in a cat. © 2021 British Small Animal Veterinary Association
10.22233/9781910443811/fig29_6_thumb.gif
10.22233/9781910443811/fig29_6.png
29.6
Ear tip curling as a result of systemic glucocorticoid therapy in a cat.
/content/figure/10.22233/9781910443811.chap29.fig29_7
29.7
Fatal thromboembolism resulting from glucocorticoid therapy. © 2021 British Small Animal Veterinary Association
10.22233/9781910443811/fig29_7_thumb.gif
10.22233/9781910443811/fig29_7.png
29.7
Fatal thromboembolism resulting from glucocorticoid therapy.
/content/figure/10.22233/9781910443811.chap29.fig29_9
29.9
Gingival hyperplasia resulting from long-term ciclosporin treatment. © 2021 British Small Animal Veterinary Association
10.22233/9781910443811/fig29_9_thumb.gif
10.22233/9781910443811/fig29_9.png
29.9
Gingival hyperplasia resulting from long-term ciclosporin treatment.
/content/figure/10.22233/9781910443811.chap29.fig29_10
29.10
Hirsutism resulting from long-term ciclosporin treatment. © 2021 British Small Animal Veterinary Association
10.22233/9781910443811/fig29_10_thumb.gif
10.22233/9781910443811/fig29_10.png
29.10
Hirsutism resulting from long-term ciclosporin treatment.